Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-06 4:50 pm Purchase | 2024-11-04 | 13D | Telesis Bio, Inc. TBIO | Northpond Ventures LP | 1,039,577 45.900% | 5,031 (+0.49%) | Filing History |
| 2024-07-18 5:42 pm Purchase | 2024-07-16 | 13D | Telesis Bio, Inc. TBIO | Northpond Ventures LP | 1,034,546 47.700% | 1,672 (+0.16%) | Filing History |
| 2024-06-10 8:40 pm Purchase | 2024-06-06 | 13D | Telesis Bio, Inc. TBIO | Northpond Ventures LP | 1,032,874 47.600% | 15,826 (+1.56%) | Filing History |
| 2023-06-23 5:10 pm Sale | 2023-06-22 | 13D | DICE Therapeutics, Inc. DICE | Northpond Ventures LP | 800,000 1.700% | -2,492,871 (-75.71%) | Filing History |
| 2023-06-15 4:15 pm Sale | 2023-03-21 | 13D | IsoPlexis Corporation ISO | Northpond Ventures LP | 0 0.000% | -8,808,531 (Position Closed) | Filing History |
| 2023-06-07 5:00 pm Purchase | 2023-06-05 | 13D | Telesis Bio, Inc. TBIO | Northpond Ventures LP | 1,017,048 47.900% | 470,152 (+85.97%) | Filing History |
| 2023-04-18 9:45 pm Unchanged | 2023-04-17 | 13D | Telesis Bio, Inc. TBIO | Northpond Ventures LP | 546,896 33.200% | 0 (Unchanged) | Filing History |
| 2023-03-29 4:02 pm Purchase | 2023-03-21 | 13G | PHENOMEX INC CELL | Northpond Ventures LP | 5,390,820 5.600% | 5,390,820 (New Position) | Filing History |
| 2022-12-21 7:06 pm Unchanged | 2022-12-21 | 13D | IsoPlexis Corporation ISO | Northpond Ventures LP | 8,808,531 22.300% | 0 (Unchanged) | Filing History |
| 2022-12-16 5:22 pm Unchanged | 2022-11-10 | 13D | Vigil Neuroscience, Inc. VIGL | Northpond Ventures LP | 4,214,498 11.800% | 0 (Unchanged) | Filing History |
| 2022-11-10 4:15 pm Unchanged | 2022-11-09 | 13D | DICE Therapeutics, Inc. DICE | Northpond Ventures LP | 3,292,871 6.900% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:40 pm Purchase | 2021-12-31 | 13G | Candel Therapeutics, Inc. CADL | Northpond Ventures LP | 1,935,215 6.700% | 1,935,215 (New Position) | Filing History |
| 2022-01-19 4:25 pm Purchase | 2022-01-11 | 13D | Vigil Neuroscience, Inc. VIGL | Northpond Ventures LP | 4,214,498 14.900% | 4,214,498 (New Position) | Filing History |
| 2021-10-22 4:28 pm Purchase | 2021-10-12 | 13D | IsoPlexis Corporation ISO | Northpond Ventures LP | 8,808,531 22.700% | 8,808,531 (New Position) | Filing History |
| 2021-09-28 06:04 am Purchase | 2021-09-17 | 13D | DICE Therapeutics, Inc. DICE | Northpond Ventures LP | 3,292,871 9.100% | 3,292,871 (New Position) | Filing History |
| 2021-07-01 5:16 pm Purchase | 2021-06-22 | 13D | Telesis Bio, Inc. TBIO | Northpond Ventures LP | 546,896 33.700% | 546,896 (New Position) | Filing History |